Michael Kinch – Cutting NIH budget could cripple drug development

Michael Kinch A proposal to slash funding for the National Institutes of Health (NIH) could severely impair the development of new, life-saving drugs, according to a new analysis by researchers at Washington University School of Medicine in St. Louis.

NIH funding supports the early research needed to develop new, innovative drugs. President Donald Trump’s proposed budget calls for cutting the NIH budget by 21 percent, or about $7.2 billion.

“NIH funding is instrumental in the early research needed to develop FDA-approved medicines,” said Kinch, also a professor of biochemistry and molecular biophysics. “Our data suggest that the development of newer drugs is becoming even more dependent on NIH funding.”

You can view the article in its entirety by clicking here. (medicine.wustl.edu)